ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle

Marisela R. Rodriguez, Kristen Monte, Larissa B. Thackray, Deborah J. Lenschow

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Human noroviruses (HuNoV) are the leading cause of nonbacterial gastroenteritis worldwide. Similar to HuNoV, murine noroviruses (MNV) are enteric pathogens spread via the fecal-oral route and have been isolated from numerous mouse facilities worldwide. Type I and type II interferons (IFN) restrict MNV-1 replication; however, the antiviral effectors impacting MNV-1 downstream of IFN signaling are largely unknown. Studies using dendritic cells, macrophages, and mice deficient in free and conjugated forms of interferon-stimulated gene 15 (ISG15) revealed that ISG15 conjugation contributes to protection against MNV-1 both in vitro and in vivo. ISG15 inhibited a step early in the viral life cycle upstream of viral genome transcription. Directly transfecting MNV-1 RNA into IFN-stimulated mouse embryonic fibroblasts (MEFs) and bone marrow-derived dendritic cells (BMDC) lacking ISG15 conjugates bypassed the antiviral activity of ISG15, further suggesting that ISG15 conjugates restrict the MNV-1 life cycle at the viral entry/uncoating step. These results identify ISG15 as the first type I IFN effector regulating MNV-1 infection both in vitro and in vivo and for the first time implicate the ISG15 pathway in the regulation of early stages of MNV-1 replication.

Original languageEnglish
Pages (from-to)9277-9286
Number of pages10
JournalJournal of virology
Volume88
Issue number16
DOIs
StatePublished - 2014

Fingerprint Dive into the research topics of 'ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle'. Together they form a unique fingerprint.

  • Cite this